The list of diseases and conditions complicated by obesity is a long one; it includes heart disease, cancer, diabetes and impaired wound healing, as well as skin infections. It is not always clear, however, in what way this ...
Researchers at CDDEP, in collaboration with leading experts in the field, have produced the "Infectious Diseases in the South-East Asia Region" report, which examines cross-boundary challenges in communicable disease control ...
Feb 23, 2021
0
3
A new treatment for eliminating surface bacteria using blue light and carvacrol, a phenol derived from edible oils, creates a photoxic, bacteria-specific reaction that does not contribute to antibiotic resistance. The technique, ...
In a study published in Gastroenterology—Researchers at Osaka City University and the Institute for Medical Science, The University of Tokyo, in collaboration with Brigham and Women's Hospital in Boston, report the intestinal ...
Feb 10, 2021
1
67
Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.
Jan 15, 2021
0
2
Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust. In an effort to ...
Jan 6, 2021
1
95
Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial pathogens with a simultaneous rapid immune response for combatting antimicrobial ...
Dec 23, 2020
0
434
New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal.
Dec 8, 2020
0
2
Periodontal or gum disease is known to be a significant risk factor of metabolic syndrome, a group of conditions increasing the risk for heart disease and diabetes. In a new study, researchers from Tokyo Medical and Dental ...
Dec 8, 2020
0
1129
An inexpensive, FDA-approved drug—cholestyramine—taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University ...
Dec 1, 2020
0
8
